• Ticker

DJIA 12,883.95 5.75 0.04%
NASDAQ 2,915.86 11.78 0.41%
S&P 500 1,349.96 2.91 0.22%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

Biogen Idec

NASDAQ:BIIB

$119.60 -$1.96 (-1.61%)

Quote as of 4:00 PM EST on 02/08/12

Extended Hours: $119.61 $0.01 (0.01%)

Quote as of 5:14 PM EST on 02/08/12 (NASDAQ)

BIIB vs. S&P 500
$119.60 -$1.96 (-1.61%)
Today's Open $121.50
Previous Close $121.56
Daily Range $118.02 - $122.11
52-Week Range $64.77 - $123.23
Market Cap $28.55B
P/E Ratio 24.12
Dividend (Yield) $0.00 (0.0%)
Volume 1,698,225
Average Daily Volume 1,700,222
Current FY EPS $6.12

BIIB Information

Description
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
Sector
Healthcare
Industry
Biotechnology

News & Commentary

BIIB's Top Competitors

BIIB

$119.60 (-1.61%)

Current stock: BIIB
AMGN

$68.06 (-1.60%)

Current stock: AMGN
GILD

$54.27 (-1.46%)

Current stock: GILD
GENZ.DL

$76.25 (0.00%)

Current stock: GENZ.DL